Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the “Company” or “Chemesis”) is pleased to announce the appointment of Josh Rosenberg as President. Josh has served on Chemesis’ Board of Directors since September 2019 and has been instrumental in the restructuring and rebuilding of its operations.
Mr. Rosenberg is a seasoned corporate executive with a proven track record in global foodservice and other product distribution as well as in executive leadership. Josh led the successful buyout of Accent Food Services (“Accent”) and transitioned the enterprise to private equity ownership and management, ultimately spearheading a major strategic shift in customer strategy and company culture which resulted in Accent progressing from a single state operator to one of the largest multi-state operations in the Unattended Retail Industry. During Josh’s six years at the helm, the company increased top line revenue more than six-fold, expanded operations to cover 11 U.S. states, and grew to encompass more than 600 associates, 14,000 customers, and to service more than 750,000 customers a day.
Mr. Rosenberg was also an Executive in the Coca-Cola corporate organization (the “Coca-Cola System”), where he led a non-traditional route to market for the foodservice division of the Coca-Cola Company after heading their $700 million, multi‐channel business. Over a progressive 18-year career, Josh rose through the ranks of the Coca Cola System, starting as a merchandiser and holding roles in sales, operations, commercial strategy, and call center management.
Josh holds a Marketing degree from Madison University, completed the KPMG QuantumShift ‘Most Promising Top 40 Entrepreneurs Program’, as well as the ‘Power of Listening Leadership Program’ at the Ross School of Business, University of Michigan, and Cornell University. Josh’s honors include being named the National Automatic Merchandising Associations’ (“NAMA”) ‘2016 Person of the Year’ and Automatic Merchandisers’ Magazine’s ‘2015 Pro to Know’.
Josh serves on several Boards of Directors, including United Strategies Group as Executive Director, and, previously, Accent Food Services as CEO/Chairman.
“I look forward to bringing my experience from the food services and mass distribution industry to provide strategic guidance to the team at Chemesis,” said Josh Rosenberg. “As the Cannabis industry evolves in the United States and globally, distribution and penetration into micro-markets will be at the fore-front of accessing the consumer base. The Company has been able to assemble an incredible portfolio of assets and I look forward to adding a global strategy to the vision.”
“Mr. Rosenberg brings incredible skills, including distribution, business management, new market penetration, and product development knowledge and expertise,” said CEO, Edgar Montero. “The remarkable experience he brings will continue to allow Chemesis to grow its business as a multi-state operator in the United States, gain distribution and penetration to markets which are currently untapped.”
Chemesis also announces the departure of Aman Parmar as President, and notes that he will remain as a Director and will also assume Chairmanship of its Board of Directors. The Company wishes to thank Mr. Parmar for his dedicated service as President.
The Company would also like to announce that, pursuant to its Share-Based Compensation Plan, the Board has approved the issuance of 2,500,000 Restricted Share Rights (“RSRs”) to certain directors, officers, contractors and employees of the Company. The RSRs were granted in recognition of the extraordinary efforts of the awardees on behalf of the Company, and as an inducement to retain such individuals.
On Behalf of The Board of Directors
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated U.S. Multi-State operator with International operations in Puerto Rico and Colombia.
The Company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it enters new markets and is committed to differentiate itself by deploying resources in markets with major opportunities. The Company operates a portfolio of brands that cater to a wide community of cannabis consumers, with focus on quality and consistency.
Chemesis has facilities in both Puerto Rico and California. The Company believes it is positioned to win additional licenses in highly competitive merit-based US states and plans to expand its footprint to ensure it maintains a first mover advantage.
1 (604) 398-3378
Forward-Looking Information: This news release contains “forward-looking information” within the meaning of applicable securities laws relating to statements regarding the Company’s business, products and future of the Company’s business, its product offerings and plans for sales and marketing, including with respect to the Company’s expectations regarding its plans for expansion and growth, ability to realize benefits from its recent corporate appointments, ability to retain its key personnel, , its plans to continue to develop dispensaries in various jurisdictions, and its ability to obtain licenses in additional jurisdictions. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking information. Such forward-looking statements are subject to risks and uncertainties that may cause actual results, performance and developments to differ materially from those contemplated by these statements depending on, among other things, the risks that the Company’s expansion and growth plans will not be realized as expected, or at all, that it will not be able to retain its key personnel, that its products and plans will vary from those stated in this news release and the Company may not be able to carry out its business plans as expected, including, but not limited to, in relation to executing on and maintaining its expansion plans, and its ability to obtain licenses in additional jurisdictions. Except as required by law, the Company expressly disclaims any obligation and does not intend to update any forward-looking statements or forward-looking information in this news release. Although the Company believes that the expectations reflected in the forward-looking information are reasonable, there can be no assurance that such expectations will prove to be correct and makes no reference to profitability based on sales reported. The statements in this news release are made as of the date of this release.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).